Q4 2025 BillionToOne Inc Earnings Call Transcript
Key Points
- BillionToOne Inc (BLLN) achieved 100% year-over-year revenue growth in 2025, surpassing the Rule of 100 with an adjusted EBITDA margin of 13%.
- The company reported a significant increase in test volumes, growing by 51% compared to 2024, and improved gross margins by 15 percentage points.
- BillionToOne Inc (BLLN) successfully launched multiple innovative products, including the 14-gene single gene NIPT and NorthStar SelectCH, enhancing its competitive advantage.
- The company secured Medicare coverage for North Star Select and signed 44 payer contracts, expanding coverage to 250 million contracted lives in the U.S.
- BillionToOne Inc (BLLN) ended the year with a strong balance sheet, holding $496 million in cash and only $50 million in term debt, positioning it for future growth.
- Despite strong growth, the company faces challenges with higher COGS in oncology tests, which could impact future margin expansion.
- BillionToOne Inc (BLLN) operates in a competitive market, facing pressure from other companies in both prenatal and oncology sectors.
- The company anticipates potential delays in health system adoption due to the need for EMR integration, which could impact projected growth.
- There is uncertainty around the timing of Medicare coverage decisions for NorthStar Response, which could affect oncology revenue projections.
- BillionToOne Inc (BLLN) must manage the complexities of scaling operations and maintaining service quality as test volumes increase significantly.
Thank you for standing by and welcome to BillionToOne's fourth quarter and full-year 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. (Operator Instrucitons)
I would now like to hand the call over to David Dyckler, Investor Relations. Please, go ahead.
Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from BillionToOne, have Oguzhan Atay, Co-Founder and Chief Executive Officer; and Ross Taylor, Chief Financial Officer. Earlier today, BillionToOne released financial results for the fourth quarter and full year ended December 31, 2025. A copy of the press release is available on the company's website.
Before we begin, I want to remind you that during this call, we may make forward-looking statements within the meaning of federal securities laws. Such statements about future events may include statements about our financial
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
